Free tools Windows power users keep installed
One-click scans. No signup required.
Evaluate a biotech analyst price target as a dated scenario, not a promise or a stand-alone buy signal. Check what security and time horizon it covers, rebuild the clinical and commercial assumptions behind it, account for funding and dilution, and compare it with other estimates only after aligning their dates and methods.
What an analyst price target does—and does not—tell you
A price target is an estimate for a particular security, based on assumptions made at a particular time and usually over a stated horizon. It is not the stock’s current price, a guaranteed future value, or proof that the analyst’s assumptions will come true. For a clinical-stage biotech, the estimate may be especially sensitive to trial results, regulatory timing, future financing, and whether a product can reach the market and win commercial adoption.
Start by recording the company and security, share class, target price, report date, stated horizon, and market price used for comparison. Confirm whether the target is expressed per common share and whether a stock split, conversion, or other capital-structure change affects the share basis. A target can become stale when market prices, company facts, or assumptions change.
Context matters, too. In Organon’s 2026 SEC-filed proxy, Morgan Stanley reviewed publicly available analyst targets as reference information in a merger analysis—not as a component of its fairness analysis. It reported an undiscounted range of $5.00–$12.00 per share and a one-year discounted range of $4.40–$10.60, using a 12.7% discount rate. The analysis was tied to the transaction and targets published on or before the unaffected date; it is not a current forecast or advice about Organon. Read the proxy’s discussion of analyst targets.
#1 Best Overall
- Read Before You Buy — No Video Output: These adapters support charging and USB 2.0 data transfer, but cannot transmit video signals. Except for standard USB webcams (which use USB data only), they are not compatible with HDMI/DisplayPort cables, video-capable USB-C hubs, or docking stations with video output.
- Convert USB-A Ports to USB-C: Designed to connect USB-C earphones, cables, flash drives, card readers, and other USB-C accessories to standard USB-A ports. Plug-and-play with no drivers or software required.
- Aluminum Alloy Housing: Built with a sturdy aluminum alloy shell that aids in heat dissipation and protects against daily wear and scratches. Designed to maintain a stable and secure connection.
- Compact & Travel-Friendly: The ultra-compact design allows the adapter to stay plugged into your device without blocking adjacent ports or adding bulk, reducing wear and tear on your original USB ports.
- 12-Month Warranty: Backed by a 12-month manufacturer warranty for peace of mind. Designed to meet strict quality control standards for reliable everyday performance.
Trace the target back to the biotech’s products and milestones
Find out which product candidates drive the estimate and what must happen before they can produce revenue. Follow the model’s logic from clinical evidence and regulatory assumptions to launch timing, eligible patients, expected uptake, pricing, competition, and the company’s share of product economics. If a partner holds commercialization rights, the company’s revenue may consist of royalties or milestone payments rather than the product’s total sales.
One common framework is risk-adjusted net present value (rNPV): forecast an asset’s cash flows, assign probabilities to possible outcomes, weight the cash flows by those probabilities, then discount them to present value. The BioIndustry Association’s guide identifies approval probability and timing, market size, patient numbers, price, and commercialization arrangements as important inputs. A practitioner guide also describes probability-adjusted cash flows and discounting as biotech asset valuation methods. These frameworks help you inspect an estimate; they do not validate an individual analyst’s inputs. BioIndustry Association guide to valuing biotech companies; Practitioner guide to biotech valuation.
Rank #2
- 5-in-1 USB-C Hub: Experience comprehensive connectivity featuring a Power Delivery input, two USB-A 2.0 ports, a USB-A 3.0 port, and an HDMI port. (Note: The USB-C power delivery input port is only for connecting an external wall charger to power your laptop and cannot power peripheral devices.)
- 90W Pass-Through Charging: Achieve optimal charging with 90W pass-through power to your laptop, supported by a total input of 100W, with the hub reserving 10W for operational efficiency. (Note: Wall charger not included.)
- Quick Data Transfers: Accelerate your productivity with rapid data transfers using a high-speed 5Gbps USB 3.0 port and two 480Mbps USB 2.0 ports.
- 4K HDMI Display: Enhance your visual experience with a hub capable of delivering 4K resolution at 30Hz in both mirror and extend modes. Please note that this hub is compatible with MacBook (macOS 12 and newer), Windows 10 and 11, ChromeOS, and laptops equipped with DP Alt Mode and Power Delivery. Note: This device is not compatible with Linux.
- What You Get: Anker USB-C Hub (5-in-1, 4K HDMI), welcome guide, 18-month warranty, and our friendly customer service.
Questions to ask about the forecast
- Which candidates, indications, or milestones contribute meaningfully to the target?
- What trial results, regulatory decisions, or additional studies does the forecast assume, and when?
- How does the analyst estimate eligible patients, uptake, price, competition, and the company’s economic share?
- Does the valuation show probabilities for key development steps and explain their source and date?
- What happens to the estimate if a milestone is delayed, an extra trial is required, or a candidate fails?
Test clinical and regulatory assumptions, not just trial phase
A trial’s phase does not by itself establish the chance that a drug will be approved. Examine the actual evidence, trial design, endpoint, follow-up, and patient population, then identify the remaining development and regulatory steps. In the analyst’s model, look for probabilities attached to meaningful steps and check whether delays, further studies, or failure are reflected.
An SEC-filed valuation example from 2019 used phase-transition estimates attributed to a 2006–2015 sourcebook and reported a 30.4% cumulative probability through regulatory approval for that analysis’s specific assumptions. That dated, deal-specific figure is not a current general success rate and should not be applied to another drug or company. Read the 2019 valuation example.
Recommended Free Tools
Rank #3
- Sleek 7-in-1 USB-C Hub: Features an HDMI port, two USB-A 3.0 ports, and a USB-C data port, each providing 5Gbps transfer speeds. It also includes a USB-C PD input port for charging up to 100W and dual SD and TF card slots, all in a compact design.
- Flawless 4K@60Hz Video with HDMI: Delivers exceptional clarity and smoothness with its 4K@60Hz HDMI port, making it ideal for high-definition presentations and entertainment. (Note: Only the HDMI port supports video projection; the USB-C port is for data transfer only.)
- Double Up on Efficiency: The two USB-A 3.0 ports and a USB-C port support a fast 5Gbps data rate, significantly boosting your transfer speeds and improving productivity.
- Fast and Reliable 85W Charging: Offers high-capacity, speedy charging for laptops up to 85W, so you spend less time tethered to an outlet and more time being productive.
- What You Get: Anker USB-C Hub (7-in-1), welcome guide, 18-month warranty, and our friendly customer service.
Check cash runway and the effect of dilution
A promising product thesis does not answer whether the company can fund development until the next value-changing milestone. For a company without established product revenue, inspect its latest filings for cash and marketable securities, operating cash use, planned trial spending, debt and other obligations, and management’s stated funding expectations. Compare available resources with expected spending through the next important milestone.
If a financing may be needed first, consider how its timing and terms could affect the number of shares and value attributable to each share. Check whether the analyst’s forecast assumes a capital raise or share count that differs from the company’s current position. Prelude Therapeutics’ 2025 annual report, for example, describes operating losses and dependence on future funding, including the risk that capital may not be available when needed or on acceptable terms. That is an issuer-specific example, but it shows why the funding path and share count belong in the analysis. Prelude Therapeutics’ 2025 annual report.
Rank #4
- Dual Converters, Infinite Potential：Includes 2× USB C male to USB A female adapters and 2× USB A male to USB C female adapters. Perfect for a wide range of uses—tablets with Bluetooth keyboards, expand USB ports on macbook, and more. Two different converters for all your daily needs
- Next-Level 10Gbps & 3A Charging: No more slow 480Mbps, this usb to usb c adapter has a transfer speed of up to 10Gbps, allowing you to do more transferring in less time. This usb adapter fits both USB A and USB C charger, supporting up to 3A fast charging
- Upgraded Exquisite Craftsmanship: With an aluminum alloy housing and metal connector, the usbc to usb adapter is extremely durable and sturdy. Rigorously tested to withstand more than 10,000 times of plugging and unplugging, ensuring long-lasting performance
- Broad Compatible: The usb c to usb adapter widely supports all USB C/ USB A devices like laptops, tablets, cellphones, car chargers, and phone chargers. Such as compatible with MacBook Pro/Air 2023/2022, Thunderbolt 4/3 Devices,Apple MagSafe Watch 9/8/7/SE/Ultra, iPad Pro 2022/2021, Samsung Galaxy S23/S20/S10, and iPhone 17/16/15 Pro. Plug and play
- Please Note: To reach 10Gbps speed, keep the cable under 3.3 ft. For USB A Male to USB C adapters, try flipping the USB C connector. USB C Male to USB A adapters support bidirectional 10Gbps transfer within 3.3 ft
Read the report’s purpose and disclosures
Check who produced the analysis, its stated purpose, and the disclosures about company relationships, investment-banking or advisory work, compensation, or positions, where disclosed. A target reproduced in a merger filing may be there as transaction reference material rather than as an independent investment recommendation.
The Organon proxy says its analyst-target review was reference information, not a component of Morgan Stanley’s fairness analysis, and cautions that targets need not reflect current trading prices and are subject to uncertainty. A separate 2026 SEC-filed proxy reported a $15.00–$21.00 range of analyst targets as of June 26, 2026, while disclosing that Lazard had been paid for financial-advisory services connected with the transaction. It also said the target review was informational and did not provide the basis for, or materially contribute to, Lazard’s fairness opinion. These are disclosures about particular transaction contexts, not evidence that all analyst reports have the same purpose or conflicts. Read the 2026 proxy discussion of analyst targets and adviser disclosures.
Do these 3 things before closing this tab:
1Fix the driver behind crashes, sound loss and screen glitches2Repair Windows errors before they cause bigger problems3Scan for outdated or missing drivers - takes under a minuteBest Value
- 5-in-1 Connectivity: Equipped with a 4K HDMI port, a 5 Gbps USB-C data port, two 5 Gbps USB-A ports, and a USB C 100W PD-IN port. Note: The USB C 100W PD-IN port supports only charging and does not support data transfer devices such as headphones or speakers.
- Powerful Pass-Through Charging: Supports up to 85W pass-through charging so you can power up your laptop while you use the hub. Note: Pass-through charging requires a charger (not included). Note: To achieve full power for iPad, we recommend using a 45W wall charger.
- Transfer Files in Seconds: Move files to and from your laptop at speeds of up to 5 Gbps via the USB-C and USB-A data ports. Note: The USB C 5Gbps Data port does not support video output.
- HD Display: Connect to the HDMI port to stream or mirror content to an external monitor in resolutions of up to 4K@30Hz. Note: The USB-C ports do not support video output.
- What You Get: Anker 332 USB-C Hub (5-in-1), welcome guide, our worry-free 18-month warranty, and friendly customer service.
Compare multiple targets on an equal basis
Do not treat a consensus average as independent confirmation. First align the target dates and stated horizons; then compare the inputs most likely to explain any gap. A higher target may assume greater clinical success, faster progress, a larger market, stronger uptake, or less dilution. A lower target may reflect different assumptions—or a different valuation method—not simply a more pessimistic view.
| Compare | What to align or inspect |
|---|---|
| Timing | Report date, target horizon, clinical and regulatory milestones, and expected launch timing |
| Clinical risk | Evidence, trial design, development-step probabilities, and the source and date of those probabilities |
| Commercial outlook | Patient population, pricing, uptake, competition, and partner economics |
| Funding and shares | Cash needs, assumed financing, share count, and dilution |
| Valuation method | Probability adjustment, discount rate, and other material assumptions |
SEC-filed transaction examples show why dates, horizons, and methods matter: Organon’s proxy distinguishes undiscounted targets from a one-year discounted range, while the other cited proxy specifies an observed target range as of June 26, 2026. Neither example establishes the right value for a different biotech stock.
Use the target as one scenario in your own analysis
For a specific company, read the latest analyst report where legitimately available and cross-check company developments against current SEC filings and official clinical or regulatory disclosures. Write down the assumptions you can verify, the assumptions you cannot, and the milestones that could change the valuation. Then decide whether the target’s scenario is plausible for the risks and time horizon you are considering; internal consistency in a model does not make its forecast certain.
Quick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
